N. Fujita et al., Failure of cdc2 promoter activation and G(2)/M transition by ANG II and AVP in vascular smooth muscle cells, AM J P-HEAR, 46(2), 1999, pp. H515-H523
Citations number
51
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
The physiological role of the vasoconstrictive hormones arginine vasopressi
n (AVP) and angiotensin Ii (ANG II) in the development of vascular hyperpla
sia is still unclear. We examined the effects of these hormones on cell cyc
le regulation of cultured rat vascular smooth muscle cells (VSMC). AVP and
ANG II were able to induce G(1)/S transition and DNA synthesis in serum-sta
rved quiescent VSMC but failed to promote further progression into G(2)/M p
hases. AVP and ANG II enhanced the expression and activity of cdk2, cyclin
E, and proliferating cell nuclear antigen but did not induce expression of
cdc2/cyclin B complex, a critical regulator of G(2)/M transition. The failu
re of cdc2 mRNn induction was found to be caused by a defect in cdc2 promot
er activation. Binding of free E2F-1 to the cdc2 promoter did not occur in
hormone-treated VSMC, which may account for the defective induction of cdc2
. The absence of cdc2 promoter activation and G(2)/M transition may be impo
rtant for the prevention of hyperplasia under physiological conditions but
underlies the hypertrophy of VSMC.